Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
10th December 2020 | Target N V Biotech | 150,000 | Open or private purchase | $8.39 | $1,258,425.00 |
10th December 2020 | Target N V Biotech | 170,000 | Open or private purchase | $8.18 | $1,391,416.00 |
9th December 2020 | Target N V Biotech | 125,000 | Open or private purchase | $8.62 | $1,077,600.00 |
10th November 2020 | Target N V Biotech | 80,000 | Open or private purchase | $9.16 | $732,472.00 |
9th November 2020 | Target N V Biotech | 80,000 | Open or private purchase | $9.05 | $724,144.00 |
6th November 2020 | Target N V Biotech | 470,335 | Open or private purchase | $8.33 | $3,919,960.02 |
5th November 2020 | Target N V Biotech | 75,000 | Open or private purchase | $10.86 | $814,230.00 |
5th November 2020 | Target N V Biotech | 100,000 | Open or private purchase | $14.26 | $1,426,230.00 |
3rd November 2020 | Target N V Biotech | 200,000 | Open or private purchase | $25.31 | $5,062,120.00 |
30th October 2020 | Target N V Biotech | 80,000 | Open or private purchase | $8.83 | $706,312.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Molecular Templates, Inc. was founded on October 17, 2001 and is headquartered in Austin, TX. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies.
21st December 2020